Kelly Bolton
Washington University in St. Louis
H-index: 32
North America-United States
Top articles of Kelly Bolton
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Modifiable risk factors are associated with clonal hematopoiesis | Cancer Research | Corey D Young Aubrey K Hubbard Pedro Saint-Maurice Irenaeus Chan Kelly L Bolton | 2024/3/22 |
Unravelling Facets of MECOM-Associated Syndrome: Somatic Genetic Rescue, Clonal Hematopoiesis and Phenotype Expansion | Blood advances | Parvathy Venugopal Peer Arts Lucy Claire Fox Annet Simons Devendra K Hiwase | 2024/4/25 |
Characterization of co-occurring clonal hematopoiesis to identify high risk clones associated with hematologic cancer risk | Cancer Research | Kara M Barnao Aubrey K Hubbard Weiyin Zhou Irenaeus Chan Duc Tran | 2024/3/22 |
Phenotypic heterogeneity associated with a novel MECOM variant: Mild thrombocytopenia to hydrops fetalis. | Pediatric Blood & Cancer | Sue L Jaspersen Andrea V Stacy Mary Claire McGlynn Catherine F Gooch David B Wilson | 2024/4/11 |
Genome and clonal hematopoiesis stability contrasts with immune, cfDNA, mitochondrial, and telomere length changes during short duration spaceflight | J Sebastian Garcia Medina S Narayanan Karolina Sienkiewicz Eliah Overbey Kirill Grigorev | 2023/5/30 | |
Cdk4/6 inhibitors as a treatment for clonal hematopoiesis | 2024/4/4 | ||
Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study | The Lancet Haematology | Catherine Cargo Elsa Bernard Tumas Beinortas Kelly L Bolton Paul Glover | 2024/1/1 |
ArCH: improving the performance of clonal hematopoiesis variant calling and interpretation | Bioinformatics | Irenaeus CC Chan Alex Panchot Evelyn Schmidt Samantha McNulty Brian J Wiley | 2024/4/1 |
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk | Clinical Cancer Research | Duc Tran J Scott Beeler Jie Liu Brian Wiley Irenaeus CC Chan | 2024/3/26 |
Abstract PO1-19-01: NRG-BR008: A Phase III Randomized Trial of Radiotherapy Optimization for Low-risk HER2-positive Breast Cancer (HERO) | Cancer Research | Lior Braunstein Melissa Mitchell Hanna Bandos William Sikov Atif Khan | 2024/5/2 |
Associations between cancer predisposition mutations and clonal hematopoiesis in patients with solid tumors | JCO Precision Oncology | Sebastià Franch-Expósito Miika Mehine Ryan N Ptashkin Kelly L Bolton Chaitanya Bandlamudi | 2023/8 |
Ivosidenib for Patients with Clonal Cytopenia of Undetermined Significance and Mutations in IDH1 | Blood | Giulia Petrone Eytan M Stein Kelly L Bolton | 2023/11/28 |
Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: RARE GENETIC DETERMINANTS OF CLONAL HEMATOPOIESIS AND PROGRESSION TO HEMATOLOGIC MALIGNANCIES | Leukemia Research | J Liu B Wiley I Chan A Batchi-Bouyou X Zong | 2023/5/1 |
Abstract P011: Clonal hematopoiesis and risk of lethal prostate cancer: a prospective cohort study with long-term follow-up | Cancer Prevention Research | Konrad H Stopsack Irenaeus C Chan Evelyn Schmidt Alex Panchot Samantha McNulty | 2023/1/1 |
How low can you go?: Methodologic considerations in clonal hematopoiesis variant calling | J Scott Beeler Kelly L Bolton | 2023/12/1 | |
Germline predisposition to clonal hematopoiesis | Jie Liu Afaf EG Osman Kelly Bolton Lucy A Godley | 2023/6/19 | |
Simultaneous assessment of somatic mutations from multiple biofluids | Luis Diaz Jr Caitlin Stewart Sonya Li James White Mitesh Patel | 2023/11/15 | |
Tumor genomic profile is associated with arterial thromboembolism risk in patients with solid cancer | Cardio Oncology | Stephanie Feldman Dipti Gupta Babak B Navi Ka-Wai Grace Ho Peter Willeit | 2023/4/1 |
Genetic causes and cardiovascular consequences of clonal hematopoiesis in the UK Biobank | Nature Cardiovascular Research | J Scott Beeler Alexander G Bick Kelly L Bolton | 2023/1 |
Targeted therapy for the treatment & prevention of life-threatening complications of infection | 2023/6/1 |
